AXSM- Axsome Therapeutics, Inc.

Insider activity in AXSM over the last quarter tilts toward selling: insiders offloaded a net 59,664 shares worth roughly $12.6M.

Classified under Biotechnology (Health Care sector), AXSM's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Pizzie Nick	72.0K	-	-
Dir	Jeffs Roger	58.4K	$14.54M	-
Dir	Coleman Mark	30.4K	$7.57M	-
Other	Maizel Ari	23.7K	-	-
Dir	Saad Mark E	11.4K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 3, 2026	Jacobson Mark L.	Chief Operating Officer	Sale+OE	10,000	$208.65	$2,086,500.00	-100%	-	-
Aug 6, 2026	Tabuteau Herriot45	Chief Executive Officer	Sale+OE	49,664	$212.19	$10,538,305.04	-87.3%	-	-
Jul 1, 2026	Tabuteau Herriot45	Chief Executive Officer	Sale+OE	49,666	$240.25	$11,932,256.50	-87.3%	-	-
Jun 11, 2026	Jeffs Roger64	Director	Sell	572	$247.65	$141,655.80	-1.0%	-	-
Jun 10, 2026	Mahony Susan	Director	Sale+OE	600	$241.70	$145,017.00	-42.0%	-	-
Jun 10, 2026	Coleman Mark	Director	Sale+OE	643	$249.00	$160,107.00	-2.1%	-	-
Jun 9, 2026	Pizzie Nick50	Chief Financial Officer	Sale+OE	33,000	$240.09	$7,922,970.00	-43.5%	-	-
Jun 9, 2026	Tabuteau Herriot45	Chief Executive Officer	Sale+OE	49,670	$241.01	$11,970,966.70	-87.3%	-	-
Jun 2, 2026	Coleman Mark	Director	Sell	17,537	$229.20	$4,019,470.43	-37.2%	-	-
Apr 22, 2026	Maizel Ari	Chief Commercial Officer	Sale+OE	7,500	$182.42	$1,368,150.00	-100%	+27.1%	-